Media Contact: Haley Otman 734 764-2220

Five U-M faculty members elected to National Academy of Medicine

Five University of Michigan professors have been elected to the highest honorary society in the United States for researchers in medicine and health.

They study everything from the brain to health care policy and cancer care, and all have demonstrated decades of expertise and achievement.

Today, F. DuBois Bowman, Justin B. Dimick, Christopher R. Friese, Karin M. Muraszko and Henry L. Paulson join a select group of fewer than 60 current and emeritus U-M faculty, and living former faculty, in the National Academy of Medicine.


F. DuBois Bowman, Ph.D.

A renowned expert in the statistical analysis of brain imaging data, F. DuBois Bowman is dean of the U-M’s School of Public Health. Bowman’s work mines massive data sets and has important implications for mental and neurological disorders such as Parkinson’s disease, Alzheimer’s disease, depression, schizophrenia, and substance addiction. His research has helped reveal brain patterns that reflect disruption from psychiatric diseases, detect biomarkers for neurological diseases, and determine more individualized therapeutic treatments. Additionally, his work seeks to determine threats to brain health from environmental exposures.

Prior to joining U-M’s School of Public Health in 2018, Bowman was chair and Cynthia and Robert Citrone-Roslyn and Leslie Goldstein Professor in the Department of Biostatistics at the Columbia University Mailman School of Public Health and a tenured professor in the Department of Biostatistics and Bioinformatics at Emory University. Bowman has also been a visiting scholar at Carnegie Mellon University and a visiting assistant professor at Johns Hopkins University, and was the founding director of Emory’s Center for Biomedical Imaging Statistics.

As a principal investigator, Bowman has received seven NIH grants, has been a co-investigator on several federally sponsored grants, and has been an integral collaborator on an international research project led by the Michael J. Fox Foundation. Bowman has also served on advisory boards for NIH programs that target underrepresented minority undergraduate students at historically black colleges and universities and has led NIH diversity pipeline training programs.

Bowman is a fellow of both the American Association for the Advancement of Science and the American Statistical Association and previously served as president of the Eastern North American Region (ENAR) of the International Biometric Society.

He earned a bachelor’s degree in mathematics from Morehouse College, a master's degree in biostatistics from U-M, and a PhD in biostatistics from the University of North Carolina, Chapel Hill.


Justin B. Dimick, M.D., M.P.H.

Justin B. Dimick, the Frederick A. Coller Distinguished Professor and Department of Surgery Chair at the University of Michigan, has been elected to the NAM for his leadership in elevating the science of health care policy evaluation, quality measurement, and comparative effectiveness research within surgical populations.

With R01 funding from the Agency for Healthcare Research and Quality (AHRQ) and National Institutes of Health (NIH), his research focuses on quality measurement, policy evaluation, and large-scale, innovative quality improvement interventions. Dimick’s research has revealed widespread variation in how surgery patients fare after their operations, and the importance of surgeon, hospital and policy factors that impact that variation. His work won him the medical school’s Clinical and Health Services Research Award, and election to the American Society of Clinical Investigation, the American Surgical Association and the Society of Clinical Surgery.

He served as the director of the Center for Healthcare Outcomes & Policy at the University of Michigan from 2014 to 2019, prior to his appointment as chair. This group includes 100+ faculty and staff focused on improving the quality and efficiency of acute and specialty care. He also served on the inaugural leadership team of the U-M Institute for Healthcare Policy and Innovation, which unites more than 600 faculty members from across campus who are engaged in health systems and policy research.

Dimick has held several national leadership positions, including president of the Association for Academic Surgery (AAS), chair of the Health Services Organization and Delivery (HSOD) Study Section at the NIH, associate editor at Annals of Surgery, and the surgical innovation editor at JAMA Surgery. He has served as an advisor on quality and health policy for several organizations, including the BlueCross BlueShield Association (BCBSA), the American College of Surgeons-National Surgical Quality Improvement Program (ACS-NSQIP), U.S. News and World Reports "Best Hospital" Rankings, and the Medicare Payment Advisory Commission (MedPAC).

Dimick is a graduate of Cornell University and Johns Hopkins Medical School. He completed his surgical training at U-M and a health services research fellowship at the Dartmouth Institute for Health Policy & Clinical Practice.


Christopher R. Friese, PhD, RN, AOCN®, FAAN

Christopher Friese is the Elizabeth Tone Hosmer Professor at the University of Michigan School of Nursing, where he focuses on measuring and improving the quality of cancer care delivery. He directs the Center for Improving Patient and Population Health. In 2020, he was appointed as the Associate Director for Cancer Control and Population Sciences at the University of Michigan Rogel Cancer Center.

He is also a faculty investigator at the University’s Institute for Healthcare Policy and Innovation. He has practiced as a staff nurse at leading cancer centers, including the University of Pennsylvania, Johns Hopkins Hospital, and the Rogel Cancer Center. Friese is a national expert in the analyses of claims data to study care quality and has executed large surveys of ambulatory oncology nurses. The author of over 90 publications, his research findings were among the first to establish a significant relationship between favorable nurse practice environments and lower surgical mortality.

As the first nurse scientist to complete a K99/R00 Pathway to Independence award from the National Institute of Nursing Research, Friese leads an interdisciplinary research program to study the quality of care delivered in understudied ambulatory oncology settings from the perspectives of patients and clinicians. He has led pivotal studies to develop valid and reliable measures of ambulatory nursing work environments. His recent work examines patterns and correlates of hazardous drug exposure in oncology nurses. His research has been funded by the National Cancer Institute, the National Institute for Occupational Safety and Health, the National Institute of Nursing Research, the Agency for Healthcare Research and Quality, the American Cancer Society, and the Robert Wood Johnson Foundation. In 2016, he was selected as Robert Wood Johnson Foundation Health Policy Fellow, where he worked on health policy initiatives in the office of Senator Robert P. Casey, Jr. (Pennsylvania). In 2018, he was appointed by the Comptroller General of the United States to a six-year team on the Patient-Centered Outcomes Research Institute (PCORI) Board of Governors.

Friese received a B.S.N.-Ph.D. from the University of Pennsylvania School of Nursing and completed a 3-year postdoctoral fellowship in Cancer Control and Outcomes at Harvard University/Dana-Farber Cancer Institute. He is also a fellow in the American Academy of Nursing and received U-M’s Henry Russel Award for Outstanding Junior Faculty. In 2017, he was installed as the inaugural holder of the Hosmer endowed chair at U-M. He holds a secondary appointment in Health Management and Policy at the School of Public Health.



Karin M. Muraszko, M.D., FAANS

Karin M. Muraszko leads Michigan Medicine’s Department of Neurosurgery, a position she has held since 2005 when she became the first woman in the country to chair an academic neurosurgery department.

The NAM elected Muraszko to the Class of 2020 for her expertise on the treatment of individuals with brain tumors and congenital neurologic anomalies. She pioneered localized injection therapy with immunotoxin for leptomeningeal disease, presented the first prospective analysis of cerebellar mutism after posterior fossa surgery, and characterized development of syrinx spinal cord cavities with Chiari 1 malformation.

Muraszko grew up in New Jersey and received her undergraduate degree from Yale University. She then continued to Columbia University in New York, where she received her medical degree, completed her residency training in neurological surgery and completed fellowships in pediatric neurosurgery.

Following her training, Muraszko was a researcher at the National Institutes for Health for two years before joining U-M.

Muraszko is board certified by the American Board of Neurological Surgeons, and is a member of the American Association of Neurological Surgeons (AANS) and the Congress of Neurological Surgeons (CNS) along with several pediatric professional associations.


Henry L. Paulson, M.D., Ph.D.

Henry L. Paulson is the Lucile Groff Professor of Neurology for Alzheimer's Disease and Related Disorders in the Michigan Medicine Department of Neurology. Paulson joined the faculty in 2007, and currently directs the Michigan Alzheimer’s Disease Center and co-directs the U-M Protein Folding Diseases Initiative.

Paulson received his medical degree and doctorate in Cell Biology from Yale University in 1990. He then completed a neurology residency and neurogenetics/movement disorders fellowships at the University of Pennsylvania. In 1997, he joined the neurology faculty at the University of Iowa, where he remained until 2007.

Paulson's research and clinical interests concern the causes and treatment of age-related neurodegenerative diseases, with an emphasis on polyglutamine diseases, Alzheimer's disease and frontotemporal dementia. In 1997, his lab described abnormal protein aggregates in the polyglutamine diseases, which now are recognized as a pathological hallmark in this important class of inherited diseases.

Using test tube, cell-based and animal models, he has contributed to advances in the understanding of various neurodegenerative diseases. His lab also has helped pioneer the use of gene silencing methods as potential therapy for the many neurological disorders caused by "toxic" mutant genes.

Nationally, Paulson has served on the scientific advisory boards of numerous disease-related national organizations, and is a past chair of the Board of Scientific Counselors at the National Institute for Neurological Disorders and Stroke at the NIH.

Among his awards, Paulson is an Ellison Medical Foundation New Scholar in Aging, a semifinalist for the W.M. Keck Foundation Young Scholars in Medical Research, a recipient of the Paul Beeson Physician Faculty Scholar in Aging Award from the American Federation for Aging Research, and a 2020 recipient of both the NIH Landis Award for Outstanding Mentorship and the American Academy of Neurology Movement Disorders Research Award.

Paulson is being elected to the NAM for his work in making fundamental discoveries regarding protein aggregation and nucleotide repeat expansions as causes of neurodegenerative diseases, and pioneering novel therapeutic strategies, including nucleotide-based gene silencing and harnessing the cell’s own quality-control machinery, for this group of devastating disorders.

NOTICE: Except where otherwise noted, all articles are published under a Creative Commons Attribution 3.0 license. You are free to copy, distribute, adapt, transmit, or make commercial use of this work as long as you attribute Michigan Medicine as the original creator and include a link to this article.

Media Inquiries:  734-764-2220 8 a.m.-5 p.m. ET 

734-936-4000 after hours, weekends, and holidays (ask for the PR person on call) [email protected] for embargoed news, videos & more